Critical drug interaction between ritonavir-boosted atazanavir regimen and non-nucleoside reverse transcriptase inhibitors-Reference-Cited by-同舟云学术

Critical drug interaction between ritonavir-boosted atazanavir regimen and non-nucleoside reverse transcriptase inhibitors

Published:2006-04-24 Issue:7 Volume:20 Page:1087-1089
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Poirier Jean-Marie,Guiard-Schmid Jean-Baptiste,Meynard Jean-Luc,Bonnard Philippe,Zouai Ouahiba,Lukiana Tuna,Jaillon Patrice,Girard Pierre-Marie,Pialoux Gilles

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference4 articles.

1. Simple and simultaneous determination of the HIV-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma by reversed-phase liquid chromatography;Poirier;Ther Drug Monit,2005

2. Interactions between atazanavir–ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients;Taburet;Antimicrob Agents Chemother,2004

3. Proton pump inhibitors do not decrease atazanavir trough plasma concentrations in HIV infected patients treated with ritonavir boosted atazanavir regimen (300/100 mg qd);Guiard-Schmid;AIDS,2005

4. Atazanavir trough plasma concentration monitoring in a cohort of HIV-1 positive individuals receiving highly active antiretroviral therapy;Winston;J Antimicrob Chemother,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients;Expert Opinion on Drug Metabolism & Toxicology;2011-02-23

2. Efavirenz in the therapy of HIV infection;Expert Opinion on Drug Metabolism & Toxicology;2009-12-13

3. Factors influencing lopinavir and atazanavir plasma concentration;Journal of Antimicrobial Chemotherapy;2009-11-06

4. Efavirenz: a decade of clinical experience in the treatment of HIV;Journal of Antimicrobial Chemotherapy;2009-09-18

5. Atazanavir;Drugs;2009-06